Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability.
Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability. JAMA Psychiatry. 2017 04 01; 74(4):379-386.